A Study Of Digital Dermatologic Management For Amivantamab-Associated Skin
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 26-007072
- Rochester, Minnesota: 26-007072
About this study
The purpose of this study is to evaluate the feasibility of a digital health system–enabled dermatologic management platform for patients receiving amivantamab-based therapy, including patient adherence to scheduled image uploads, timeliness of clinician feedback, and the impact on early detection and management of dermatologic adverse events.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Adults between the ages of 18 and 99
Treated at Mayo Clinic Rochester and Florida campuses
Either will be starting Amivantamab within 2 weeks of signing consent, or have started Amivantamab in the last 4 months, from date of consent.
Exclusion Criteria:
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 06/22/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Jacksonville, Fla.
Mayo Clinic principal investigator |
Contact us for the latest status |
|
Rochester, Minn.
Mayo Clinic principal investigator |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available